BURLINGTON, Mass. (AP) _ Flexion Therapeutics Inc. (FLXN) on Thursday reported a loss of $33.5 million in its fourth quarter.
The Burlington, Massachusetts-based company said it had a loss of 88 cents per share.
The specialty pharmaceutical companies that specializes in pain relief posted revenue of $23.7 million in the period.
For the year, the company reported that its loss narrowed to $149.8 million, or $3.93 per share. Revenue was reported as $73 million.
Flexion Therapeutics shares have decreased 51% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $10.15, a fall of 19% in the last 12 months.